Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin |
| |
Authors: | Phung Thuy L Ziv Keren Dabydeen Donnette Eyiah-Mensah Godfred Riveros Marcela Perruzzi Carole Sun Jingfang Monahan-Earley Rita A Shiojima Ichiro Nagy Janice A Lin Michelle I Walsh Kenneth Dvorak Ann M Briscoe David M Neeman Michal Sessa William C Dvorak Harold F Benjamin Laura E |
| |
Institution: | Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA. |
| |
Abstract: | Endothelial cells in growing tumors express activated Akt, which when modeled by transgenic endothelial expression of myrAkt1 was sufficient to recapitulate the abnormal structural and functional features of tumor blood vessels in nontumor tissues. Sustained endothelial Akt activation caused increased blood vessel size and generalized edema from chronic vascular permeability, while acute permeability in response to VEGF-A was unaffected. These changes were reversible, demonstrating an ongoing requirement for Akt signaling for the maintenance of these phenotypes. Furthermore, rapamycin inhibited endothelial Akt signaling, vascular changes from myrAkt1, tumor growth, and tumor vascular permeability. Akt signaling in the tumor vascular stroma was sensitive to rapamycin, suggesting that rapamycin may affect tumor growth in part by acting as a vascular Akt inhibitor. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|